Stay updated on Elranatamab Combo in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record details. The surrounding site chrome (header/navigation) remains visible in the error state.
    Difference
    21%
    Check dated 2026-09-20T20:37:28.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The related topics section now includes 'Multiple myeloma' and 'MedlinePlus Genetics', broadening cross-references to the study's disease and an external genetics resource. These additions reflect taxonomy indexing rather than changes to study design or eligibility.
    Difference
    0.1%
    Check dated 2026-09-13T18:43:20.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page no longer lists the condition 'Multiple myeloma' and removes the 'related topics' section such as MedlinePlus Genetics. This changes how the study is contextualized and which informational resources are linked.
    Difference
    0.1%
    Check dated 2026-09-06T22:26:06.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The Locations section has been expanded to 139 sites across the UK, Switzerland, South Korea, Germany, Belgium, Austria, and other countries, updating the prior total and listing specific centers such as Royal Stoke University Hospital, Churchill Hospital, Western General Hospital, Beatson West of Scotland Cancer Centre, Inselspital Bern, Ewha Womans University Seoul Hospital, and more.
    Difference
    1%
    Check dated 2026-08-30T21:55:03.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page now includes new related-topic references for disease information, specifically listing 'Multiple myeloma' and the MedlinePlus Genetics section.
    Difference
    0.1%
    Check dated 2026-08-23T20:15:31.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    - Deleted the core disease keyword 'Multiple myeloma' and the related topics resource 'MedlinePlus Genetics'. This changes how the study's focus is presented and reduces quick access to background information.
    Difference
    0.1%
    Check dated 2026-08-16T16:31:27.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.